New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
CMS-lca
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
OIG Monthly Work Plan Review: August 2019
...
Already a member? Log in here
How to Determine Date of Service for Part B Billing of Outpatient Lab Tests
From – Lab Compliance Advisor
Date of service rules affect whether outpatient lab tests are part of the Hospital Outpatient Prospective Payment System (HOPPS) bundled payment or…
Already a member? Log in here
Government Shutdown: The Impact on the Agencies that Regulate Labs
...
Already a member? Log in here
Medicare Reimbursement: CMS Provides Needed PAMA Relief—But Newly Covered Hospital Labs Must Report in 2019
From – Lab Compliance Advisor
The battle between CMS and the lab industry over Medicare Part B pricing for lab tests could be on the road to…
Already a member? Log in here
Provider Fined for Not Taking Compliance Measures Required by Its CIA
...
Already a member? Log in here
Correction: PAMA Relief—CMS 1450 14x TOB Labs DO Count!
...
Already a member? Log in here
How to Adjust to the April 2018 Medicare Beneficiary Cards
By Sean McSweeney bio
In a press release on May 30, 2017, the Centers for Medicare & Medicaid Services (CMS) commented regarding their fraud prevention initiative program and their planned changes regarding…
